Effect of silica on phospholipase D activity in rat alveolar macrophages

Ind Health. 1998 Jul;36(3):258-62. doi: 10.2486/indhealth.36.258.

Abstract

Silica may act as a stimulator of pulmonary inflammation and fibrosis. The effect of silica on phospholipase D (PLD) activity assayed as accumulation of [3H]phosphatidylethanol ([3H]PtdEt) was examined in [3H]palmitic acid-labeled primary cultures of rat alveolar macrophages. Silica induced a rapid accumulation of [3H]PtdEt in a time (0, 15, 30 and 45 min)- and concentration (0.5, 1.0, 2.5 and 5.0 mg/ml)-dependent manner indicating PLD activation. This silica-stimulated PLD activity was attenuated by the pretreatment with calcium chelator ethylene glycol-bis(beta-aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA) or/and 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid acetoxymethyl ester (BAPTA/AM) (EGTA: 54.3 +/- 8.6%, BAPTA/AM: 67.5 +/- 7.8% and EGTA + BAPTA/AM: 35.8 +/- 2.9, respectively). Also, silica-induced PLD activation was partially inhibited by the pretreatment with nonspecific phospholipase C (PLC) and PLD inhibitor (neomycin; 66.4 +/- 4.8%) or specific PLC inhibitor (U73122; 70.8 +/- 4.6%). Sphingosine as a protein kinase C (PKC) inhibitor did not change silica-induced PLD activity indicating that PKC might not play a role in PLD activation by silica. Based on these results, we concluded that a silica-stimulated phospholipase D activity is present in the rat alveolar macrophages and is predominantly regulated by PLC-mediated intracellular calcium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Calcium / metabolism
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Macrophages, Alveolar / drug effects*
  • Macrophages, Alveolar / enzymology*
  • Male
  • Phospholipase D / drug effects*
  • Phospholipase D / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Silicon Dioxide / pharmacology*
  • Sphingosine / pharmacology
  • Type C Phospholipases / metabolism

Substances

  • Chelating Agents
  • Egtazic Acid
  • Silicon Dioxide
  • Type C Phospholipases
  • Phospholipase D
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Sphingosine
  • Calcium